한글목차

세계 항콕시듐제 시장의 미래는 동물병원과 소매 약국 시장에 기회가 있을 것으로 보입니다. 세계 항콕시듐제 시장은 2025년부터 2031년까지 CAGR 5.7%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 콕시듐증 유병률 증가, 수의학 발전, 육류 및 가금류 제품에 대한 수요 증가입니다.

• Lucintel은 동물 카테고리에서 반려동물은 예측 기간 동안 계속해서 큰 부문을 차지할 것으로 예상하고 있습니다.
• 유통 채널 부문에서는 동물병원이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

항콕시듐제 시장의 전략적 성장 기회

항콕시듐제 시장은 단백질 수요 증가로 인한 세계 가금류 생산량 증가로 인해 큰 성장이 예상됩니다. 이러한 역동적인 환경은 업계 관계자들에게 많은 전략적 기회를 제공하고 있습니다. 제형 혁신, 지속가능한 관행으로의 전환, 동물 복지에 대한 소비자의 인식이 높아지면서 시장 역학이 재편되고 있습니다. 이러한 트렌드를 활용함으로써 기업은 시장에서의 입지를 강화하고 진화하는 고객 니즈에 대응할 수 있기 때문에 전략적 성장 기회를 식별하고 추구하는 것이 필수적입니다.

• 신흥 시장 진출 : 닭고기 생산이 증가하는 신흥 시장에는 큰 성장 잠재력이 있습니다. 기업들은 동남아시아, 아프리카 등의 지역에서 파트너십과 유통 채널을 모색하고 항콕시듐제에 대한 수요 증가를 포착하여 매출과 시장 점유율을 높일 수 있습니다.
• 새로운 제형 개발 : 연구개발에 투자하여 새로운 제형을 개발하면, 혼잡한 시장에서도 제품을 차별화할 수 있습니다. 혁신적인 전달 시스템과 병용요법에 집중함으로써 기업은 효능을 높이고 내성을 줄여 콕시듐증에 대한 고급 솔루션을 원하는 생산자에게 대응할 수 있습니다.
• 예방적 위생 솔루션에 집중 : 업계가 예방적 위생 전략으로 전환함에 따라, 전체 관리 프로그램에 통합된 항콕시듐제는 큰 기회를 제공합니다. 콕시듐증을 표적으로 삼으면서도 전체 우군의 건강을 지원하는 제품을 개발함으로써 종합적인 솔루션을 원하는 생산자들을 끌어들일 수 있습니다.
• 기술 제공업체와의 협업 : 기술 기업과의 파트너십을 통해 데이터에 기반한 인사이트와 정밀 농업 기술을 통해 제품 제공을 강화할 수 있습니다. 이러한 기술을 항콕시듐 솔루션에 통합하면 투약 정확도를 높이고, 양떼를 모니터링할 수 있으며, 궁극적으로 건강 상태 개선과 매출 증가로 이어질 수 있습니다.
• 지속가능한 제품 개발 : 제품 개발에 있어 지속가능성을 중시하면 소비자의 선호도와 규제 요구 사항을 충족시킬 수 있습니다. 친환경 식물 유래 항콕시듐제를 개발하면 시장의 관심을 끌 수 있을 뿐만 아니라 기업을 지속가능한 농업의 선두주자로 자리매김하여 장기적인 성장을 촉진할 수 있습니다.

항콕시듐제 시장에는 신흥 시장 진출, 새로운 제형 개발, 예방 위생 솔루션에 대한 집중, 기술 제공업체와의 제휴, 지속가능한 제품 개발 등 몇 가지 전략적 성장 기회가 있습니다. 이러한 수단을 추구함으로써 기업은 경쟁력을 강화하고, 진화하는 시장 요구에 대응하며, 빠르게 변화하는 업계에서 확고한 입지를 확보할 수 있습니다.

항콕시듐제 시장 촉진요인 및 과제

항콕시듐제 시장은 생산 관행과 소비자 수요에 영향을 미치는 다양한 요인으로 인해 큰 변화를 겪고 있습니다. 전 세계 가금류 소비가 증가함에 따라 콕시듐증에 대한 효과적인 해결책에 대한 필요성이 점점 더 커지고 있습니다. 그러나 이 시장은 규제 압력과 소비자 선호도 변화라는 도전에 직면해 있습니다. 이해관계자들이 이러한 복잡한 상황을 극복하고 성장 기회를 활용하기 위해서는 촉진요인과 도전 과제를 모두 이해하는 것이 필수적입니다.

항콕시듐제 시장을 이끄는 요인은 다음과 같습니다:

• 가금류 생산량 증가 : 가금류 생산량 증가 : 가금류 제품에 대한 수요 증가는 항콕시듐제 시장의 주요 촉진요인입니다. 인구가 증가하고 식습관이 고단백질 소비로 전환됨에 따라 양계업자들은 동물의 건강과 생산성을 보장하기 위한 효과적인 솔루션을 찾고 있으며, 이는 항콕시듐제에 대한 수요 증가로 이어집니다.
• 동물 건강에 대한 인식의 증가 : 소비자와 생산자 사이에서 동물의 복지와 건강에 대한 관심이 높아지고 있습니다. 이해관계자들은 인도적인 농업 관행을 보장하면서 가축의 건강과 생산성을 유지하기 위해 노력하고 있으며, 이러한 인식이 효과적인 항콕시듐 약품의 채택을 촉진하고 있습니다.
• 대체 약물에 대한 규제 지원 : 가축에 대한 항생제 사용에 대한 규제가 강화되면서 대체 항콕시듐제 개발이 촉진되고 있습니다. 이러한 변화는 제조업체들이 새로운 가이드라인을 준수하는 혁신적인 솔루션에 투자하도록 유도하여 시장 성장을 더욱 촉진하고 있습니다.
• 기술 발전 : 제형 및 약물전달 시스템의 혁신으로 항콕시듐제의 효능이 향상되고 있습니다. 연구개발과 기술의 발전으로 내성을 최소화한 제품 개발이 가능해져 효과적인 치료를 원하는 생산자에게 매력적인 제품이 되고 있습니다.
• 연구개발 투자 증가 : 연구개발에 대한 관심이 높아지면서 항콕시듐제 시장의 기술 혁신이 촉진되고 있습니다. 각 업체들은 새로운 활성 성분의 발견과 병용요법에 투자하여 현재의 수요를 충족시킬 뿐만 아니라 미래를 위한 경쟁력을 강화하고 있습니다.

항콕시듐제 시장의 과제는 다음과 같습니다:

• 규제적 과제 : 변화하는 규제 환경은 제조업체에게 큰 도전이 되고 있습니다. 엄격한 안전성 및 유효성 기준을 준수하는 것은 제품 개발 일정을 지연시키고, 비용을 증가시키며, 신제품의 시장 진입을 복잡하게 만듭니다.
• 시장 포화 : 시장이 성장함에 따라 기존 기업 간의 경쟁이 심화되어 시장이 포화상태에 빠질 수 있습니다. 이러한 포화 상태는 가격 하락과 수익률 압박으로 이어져 기업은 지속적인 성장을 유지하기가 어려워집니다.
• 소비자 선호도 변화 : 유기농 및 무항생제 제품에 대한 소비자 선호도 변화는 기존의 항콕시듐 전략을 어렵게 만들 수 있습니다. 생산자는 이러한 선호도에 대응하기 위해 새로운 적응형 솔루션에 대한 투자가 필요합니다.

결론적으로, 항콕시듐제 시장은 닭고기 생산량 증가, 동물 건강에 대한 인식 증가, 대체품에 대한 규제 당국의 지원, 기술 발전, 연구개발에 대한 투자 증가에 의해 주도되고 있습니다. 그러나 규제적 장애물, 시장 포화, 소비자 선호도 변화 등 여러 가지 도전과제를 해결해야 합니다. 이러한 역학을 이해하면 이해관계자들이 시장의 복잡성을 극복하고 성장 기회를 포착하는 데 도움이 될 수 있습니다.

목차

제1장 주요 요약

제2장 세계의 항콕시듐제 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2019년부터 2031년까지 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 항콕시듐제 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 항콕시듐제 시장 : 동물별
  • 가축
  • 반려동물
• 세계의 항콕시듐제 시장 : 약효별
  • 콕시듐 억제
  • 콕시듐 방제
• 세계의 항콕시듐제 시장 : 약물 종류별
  • 이오노포어
  • 항생제
  • 설폰아미드
  • 화학 유도체
  • 기타
• 세계의 항콕시듐제 시장 : 유통 채널별
  • 동물 병원
  • 소매 약국
  • 기타

제4장 2019년부터 2031년까지 시장 동향과 예측 분석 : 지역별

• 지역별 세계의 항콕시듐제 시장
• 북미의 항콕시듐제 시장
• 유럽의 항콕시듐제 시장
• 아시아태평양의 항콕시듐제 시장
• 기타 지역의 항콕시듐제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 동물별 세계의 : 세계의 항콕시듐제 시장 성장 기회
  • 약효별 세계의 : 세계의 항콕시듐제 시장 성장 기회
  • 약물 종류별 : 세계의 항콕시듐제 시장 성장 기회
  • 유통 채널별 : 세계의 항콕시듐제 시장 성장 기회
  • 지역별 : 세계의 항콕시듐제 시장 성장 기회
• 세계의 항콕시듐제 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 항콕시듐제 시장 생산능력 확대
  • 세계의 항콕시듐제 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Zoetis
• Phibro Animal Health Corporation
• Huvepharma
• Elanco
• Biochem Pharma
• Ceva
• Impextraco
• Virbac
• Boehringer Ingelheim International
• MSD Animal Health

영문목차

The future of the global anticoccidial drug market looks promising with opportunities in the veterinary hospital and retail pharmacy markets. The global anticoccidial drug market is expected to grow with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of coccidiosis, growing developments in veterinary medicine, and expanding demand for meat and poultry products.

• Lucintel forecasts that, within the animal category, companion animals will remain a larger segment over the forecast period.
• Within the distribution channel category, veterinary hospital is expected to witness the highest growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Anticoccidial Drug Market

The anticoccidial drug market is evolving rapidly, responding to the growing demand for poultry products and increasing concerns about drug resistance and animal welfare. Innovations in formulations and a shift toward sustainable practices are shaping this market. Regulatory changes and consumer preferences are also driving the development of alternative therapies and natural products. As stakeholders adapt to these challenges, several emerging trends are becoming prominent in the anticoccidial landscape.

• Shift to Natural Products: There is a notable shift toward natural and plant-based anticoccidials as consumers and producers alike seek alternatives to traditional chemical treatments. This trend is fueled by rising awareness of antibiotic resistance and the demand for organic poultry products.
• Innovation in Formulations: The market is witnessing significant innovations in drug formulations, including the development of new delivery systems and combination therapies. These advancements aim to enhance the efficacy of existing products while minimizing the risk of resistance development among coccidia.
• Increased R&D Investment: Pharmaceutical companies are ramping up their research and development efforts to discover novel anticoccidial agents. This trend is driven by the need for more effective solutions and the desire to comply with stricter regulations regarding drug use in livestock.
• Focus on Animal Welfare: Growing awareness of animal welfare issues is prompting producers to adopt more humane farming practices. This shift influences the development of anticoccidials that not only improve health outcomes for poultry but also align with ethical considerations.
• Regulatory Changes: Stricter regulatory frameworks concerning drug usage and safety are emerging globally. These changes compel manufacturers to enhance their product safety profiles and develop more sustainable and effective anticoccidial solutions to meet compliance requirements.

The anticoccidial drug market is undergoing transformative changes characterized by a move toward natural products, innovative formulations, increased research investment, a focus on animal welfare, and evolving regulatory landscapes. These trends not only address current market demands but also pave the way for a more sustainable and effective approach to managing coccidiosis in livestock.

Recent Developments in the Anticoccidial Drug Market

The anticoccidial drug market is evolving in response to growing challenges such as antibiotic resistance, changing consumer preferences, and stricter regulations. Key players are investing in research and development to create more effective and sustainable solutions. As the demand for poultry products increases globally, advancements in formulations and a focus on animal welfare are shaping the landscape. Understanding these recent developments is crucial for stakeholders aiming to navigate the complexities of the market and adapt to emerging trends.

• New Drug Approvals: Recent approvals of novel anticoccidial agents have expanded the market, providing poultry producers with more options to combat coccidiosis. These new products often feature improved efficacy and safety profiles, meeting the demand for alternatives to traditional treatments.
• Enhanced Combination Therapies: The use of combination therapies has gained traction, as they offer synergistic effects against various strains of coccidia. By combining multiple active ingredients, these formulations enhance effectiveness while reducing the likelihood of resistance, making them increasingly popular among producers.
• Focus on Resistance Management: Addressing antibiotic resistance has become a priority in the anticoccidial market. New strategies, such as rotating different classes of anticoccidials and integrating non-pharmaceutical interventions, are being developed to mitigate resistance and maintain treatment efficacy.
• Integration of Technology: Advancements in technology, including precision agriculture and data analytics, are influencing the anticoccidial market. Producers are utilizing these tools to optimize dosing regimens and monitor health outcomes, leading to more efficient use of anticoccidials and better flock management.
• Emphasis on Sustainable Practices: The growing emphasis on sustainability is driving the development of eco-friendly anticoccidials. Companies are increasingly focusing on plant-based formulations and reducing environmental impact, aligning their products with consumer preferences for sustainable and ethically produced food.

The anticoccidial drug market is experiencing significant developments marked by new drug approvals, enhanced combination therapies, a focus on resistance management, the integration of technology, and an emphasis on sustainable practices. These advancements not only respond to current challenges but also position the industry for future growth, ultimately benefiting producers and consumers alike.

Strategic Growth Opportunities for Anticoccidial Drug Market

The anticoccidial drug market is poised for significant growth as global poultry production continues to rise, driven by increasing protein demand. This dynamic landscape presents numerous strategic opportunities for industry players. Innovations in formulations, a shift toward sustainable practices, and growing consumer awareness about animal welfare are reshaping market dynamics. By capitalizing on these trends, companies can enhance their market position and meet evolving customer needs, making it essential to identify and pursue strategic growth opportunities.

• Expansion into Emerging Markets: There is substantial potential for growth in emerging markets where poultry production is on the rise. Companies can explore partnerships and distribution channels in regions like Southeast Asia and Africa to tap into increasing demand for anticoccidial drugs, boosting sales and market share.
• Development of Novel Formulations: Investing in research and development to create novel formulations can differentiate products in a crowded market. By focusing on innovative delivery systems and combination therapies, companies can enhance efficacy and reduce resistance, catering to producers looking for advanced solutions to coccidiosis.
• Focus on Preventive Health Solutions: As the industry shifts toward preventive health strategies, anticoccidial drugs that integrate into holistic management programs present a significant opportunity. Developing products that support overall flock health while targeting coccidiosis can attract producers seeking comprehensive solutions.
• Collaboration with Technology Providers: Forming partnerships with technology firms can enhance product offerings through data-driven insights and precision agriculture techniques. Integrating these technologies into anticoccidial solutions can improve dosing accuracy and flock monitoring, ultimately leading to better health outcomes and increased sales.
• Sustainable Product Development: Emphasizing sustainability in product development can align with consumer preferences and regulatory demands. Creating eco-friendly, plant-based anticoccidials can not only capture market interest but also position companies as leaders in sustainable agriculture, driving long-term growth.

The anticoccidial drug market presents several strategic growth opportunities, including expansion into emerging markets, the development of novel formulations, a focus on preventive health solutions, collaboration with technology providers, and sustainable product development. By pursuing these avenues, companies can enhance their competitive edge, respond to evolving market needs, and secure a robust position in this rapidly changing industry.

Anticoccidial Drug Market Driver and Challenges

The anticoccidial drug market is experiencing significant transformation, driven by various factors that influence production practices and consumer demand. As global poultry consumption rises, the need for effective solutions to combat coccidiosis becomes increasingly critical. However, this market also faces challenges such as regulatory pressures and shifting consumer preferences. Understanding both the drivers and challenges is essential for stakeholders aiming to navigate the complexities of this evolving landscape and capitalize on growth opportunities.

The factors responsible for driving the anticoccidial drug market include:

• Rising Poultry Production: The increasing demand for poultry products is a primary driver of the anticoccidial drug market. As populations grow and diets shift toward higher protein consumption, poultry producers seek effective solutions to ensure animal health and productivity, leading to greater demand for anticoccidials.
• Growing Awareness of Animal Health: There is a heightened focus on animal welfare and health among consumers and producers alike. This awareness drives the adoption of effective anticoccidial drugs, as stakeholders aim to maintain flock health and productivity while ensuring humane farming practices.
• Regulatory Support for Alternatives: Stricter regulations on antibiotic use in livestock are encouraging the development of alternative anticoccidial agents. This shift is prompting manufacturers to invest in innovative solutions that comply with new guidelines, further driving growth in the market.
• Technological Advancements: Innovations in drug formulations and delivery systems are enhancing the efficacy of anticoccidials. Advances in research and technology allow for the development of products that minimize resistance, making them more appealing to producers seeking effective treatments.
• Increased Investment in R&D: The rising focus on research and development is driving innovation in the anticoccidial market. Companies are investing in the discovery of new active ingredients and combination therapies, which not only meet current demands but also position them competitively for the future.

Challenges in the anticoccidial drug market are:

• Regulatory Challenges: The evolving regulatory landscape poses significant challenges for manufacturers. Compliance with stringent safety and efficacy standards can slow down product development timelines and increase costs, complicating market entry for new products.
• Market Saturation: As the market grows, increased competition among existing players can lead to market saturation. This saturation may drive down prices and squeeze profit margins, making it difficult for companies to maintain sustainable growth.
• Consumer Preference Shifts: Changing consumer preferences toward organic and antibiotic-free products can challenge traditional anticoccidial strategies. Producers may need to adapt their practices to meet these preferences, requiring investment in new, compliant solutions.

In conclusion, the anticoccidial drug market is driven by rising poultry production, growing awareness of animal health, regulatory support for alternatives, technological advancements, and increased investment in R&D. However, challenges such as regulatory hurdles, market saturation, and shifting consumer preferences must be addressed. Understanding these dynamics will help stakeholders navigate the complexities of the market and seize growth opportunities.

List of Anticoccidial Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies anticoccidial drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anticoccidial drug companies profiled in this report include-

• Zoetis
• Phibro Animal Health Corporation
• Huvepharma
• Elanco
• Biochem Pharma
• Ceva
• Impextraco
• Virbac
• Boehringer Ingelheim International
• MSD Animal Health

Anticoccidial Drug by Segment

The study includes a forecast for the global anticoccidial drug market by animal, drug action, drug class, distribution channel, and region.

Anticoccidial Drug Market by Animal [Analysis by Value from 2019 to 2031]:

• Livestock Animals
• Companion Animals

Anticoccidial Drug Market by Drug Action [Analysis by Value from 2019 to 2031]:

• Coccidiostatic
• Coccidiocidal

Anticoccidial Drug Market by Drug Class [Analysis by Value from 2019 to 2031]:

• Ionophore
• Antibiotic
• Sulphonamides
• Chemical Derivative
• Others

Anticoccidial Drug Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Veterinary Hospitals
• Retail Pharmacy
• Others

Anticoccidial Drug Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Anticoccidial Drug Market

The anticoccidial drug market is witnessing significant advancements driven by increasing poultry production, rising awareness of animal health, and regulatory changes. Key players are focusing on innovative formulations and alternative therapies to combat drug resistance and improve efficacy. Countries like the United States, China, Germany, India, and Japan are experiencing varied developments influenced by local market demands, regulatory frameworks, and agricultural practices. Understanding these regional dynamics can provide insights into the ultimate trajectory of the global anticoccidial market.

• United States: The U.S. market is seeing a shift toward natural and organic anticoccidials, driven by consumer demand for antibiotic-free poultry. Regulatory bodies are also encouraging alternatives to traditional chemicals to enhance animal welfare.
• China: Rapid growth in poultry farming has prompted Chinese companies to invest in R&D for new anticoccidial agents, focusing on improving efficacy and reducing side effects. Government support for innovative agriculture further boosts these initiatives.
• Germany: In Germany, stringent regulations on antibiotic use are prompting the development of new anticoccidial drugs with lower resistance profiles. Research institutions collaborate with pharmaceutical companies to enhance product safety and effectiveness.
• India: The Indian anticoccidial market is expanding due to increasing poultry consumption and investment in animal health. Local manufacturers are developing cost-effective solutions while also exploring herbal and alternative treatments.
• Japan: The Japanese market is characterized by advanced formulations that aim to reduce environmental impact. The focus on sustainability drives the development of plant-based anticoccidials, aligning with consumer preferences for eco-friendly products.

Features of the Global Anticoccidial Drug Market

Market Size Estimates: Anticoccidial drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Anticoccidial drug market size by various segments, such as by animal, drug action, drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Anticoccidial drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different animals, drug actions, drug classes, distribution channels, and regions for the anticoccidial drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anticoccidial drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the anticoccidial drug market by animal (livestock animals and companion animals), drug action (coccidiostatic and coccidiocidal), drug class (ionophore, antibiotic, sulphonamides, chemical derivative, and others), distribution channel (veterinary hospitals, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Anticoccidial Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Anticoccidial Drug Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Anticoccidial Drug Market by Animal
  • 3.3.1: Livestock Animals
  • 3.3.2: Companion Animals
• 3.4: Global Anticoccidial Drug Market by Drug Action
  • 3.4.1: Coccidiostatic
  • 3.4.2: Coccidiocidal
• 3.5: Global Anticoccidial Drug Market by Drug Class
  • 3.5.1: Ionophore
  • 3.5.2: Antibiotic
  • 3.5.3: Sulphonamides
  • 3.5.4: Chemical Derivative
  • 3.5.5: Others
• 3.6: Global Anticoccidial Drug Market by Distribution Channel
  • 3.6.1: Veterinary Hospitals
  • 3.6.2: Retail Pharmacy
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Anticoccidial Drug Market by Region
• 4.2: North American Anticoccidial Drug Market
  • 4.2.1: North American Market by Animal: Livestock Animals and Companion Animals
  • 4.2.2: North American Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.3: European Anticoccidial Drug Market
  • 4.3.1: European Market by Animal: Livestock Animals and Companion Animals
  • 4.3.2: European Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.4: APAC Anticoccidial Drug Market
  • 4.4.1: APAC Market by Animal: Livestock Animals and Companion Animals
  • 4.4.2: APAC Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.5: ROW Anticoccidial Drug Market
  • 4.5.1: ROW Market by Animal: Livestock Animals and Companion Animals
  • 4.5.2: ROW Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Anticoccidial Drug Market by Animal
  • 6.1.2: Growth Opportunities for the Global Anticoccidial Drug Market by Drug Action
  • 6.1.3: Growth Opportunities for the Global Anticoccidial Drug Market by Drug Class
  • 6.1.4: Growth Opportunities for the Global Anticoccidial Drug Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Anticoccidial Drug Market by Region
• 6.2: Emerging Trends in the Global Anticoccidial Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Anticoccidial Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Anticoccidial Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Zoetis
• 7.2: Phibro Animal Health Corporation
• 7.3: Huvepharma
• 7.4: Elanco
• 7.5: Biochem Pharma
• 7.6: Ceva
• 7.7: Impextraco
• 7.8: Virbac
• 7.9: Boehringer Ingelheim International
• 7.10: MSD Animal Health